Evidence map›Paper›PMID 19726546›Full record

ArticleAmerican journal of physiology. Renal physiology2009

Rac1 promotes TGF-beta-stimulated mesangial cell type I collagen expression through a PI3K/Akt-dependent mechanism.

Susan C Hubchak, Erin E Sparks, Tomoko Hayashida, H William Schnaper

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Promoting collagen synthesis: a viable strategy to combat skin ageing.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. DOCK-t(w)o Pleural Fibrosis.American journal of respiratory cell and molecular biology · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Susan C HubchakDivision of Kidney Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. s-hubchak@northwestern.edu
Erin E Sparks
Tomoko Hayashida
H William Schnaper
Northwestern University · USMemorial Medical Center · USVanderbilt University Medical Center · US

Funding

Signaling Pathways in Renal FibrogenesisR01DK049362 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHNAPER, H WILLIAM · 1994 to 2014
$4.0M
TGF-beta and Cytoskeletal Signaling in Mesangial CellR21DK068637 · NIDDK · NORTHWESTERN UNIVERSITY · PI SCHNAPER, H WILLIAM · 2004 to 2005
$279k
Signaling Pathways in Renal FibrogenesisR56DK049362 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHNAPER, H WILLIAM · 2008 to 2008
$258k
NIDDK NIH HHS DK-49362NIDDK NIH HHS DK-68637NIDDK NIH HHS R01 DK049362NIDDK NIH HHS R56 DK049362
6 · The paper itself

Abstract

Transforming growth factor (TGF)-beta is a central mediator in the progression of glomerulosclerosis, leading to accumulation of aberrant extracellular matrix proteins and inappropriate expression of smooth muscle alpha-actin in the kidney. Previously, we reported that disrupting the cytoskeleton diminished TGF-beta-stimulated type I collagen accumulation in human mesangial cells. As cytoskeletal signaling molecules, including the Rho-family GTPases, have been implicated in fibrogenesis, we sought to determine the respective roles of RhoA and Rac1 in HMC collagen I expression. TGF-beta1 activated both RhoA and Rac1 within 5 min of treatment, and this activation was dependent on the kinase activity of the type I TGF-beta receptor. TGF-beta1-stimulated induction of type I collagen mRNA expression and promoter activity was diminished by inhibiting Rac1 activity and was increased by a constitutively active Rac1 mutant, whereas inhibiting RhoA activity had no such effect. Rac1 activation required phosphatidylinositol-3-kinase (PI3K) activity. Furthermore, the PI3K antagonist, LY294002, reduced TGF-beta1-stimulated COL1A2 promoter activity and Rac1 activation. It also partially blocked active Rac1-stimulated collagen promoter activity, suggesting that PI3K activity contributes to both TGF-beta activation of Rac1 and signal propagation downstream of Rac1. Thus, while both Rac1 and RhoA are rapidly activated in response to TGF-beta1 in human mesangial cells, only Rac1 activation enhances events that contribute to mesangial cell collagen expression, through a positive feedback loop involving PI3K.

Indexed as

ActinsBlotting, NorthernCollagen Type IFibrosisHumansKidneyKidney CortexMesangial CellsOncogene Protein v-aktPhosphatidylinositol 3-KinasesPlasmidsrac1 GTP-Binding ProteinrhoA GTP-Binding Proteinrho GTP-Binding ProteinsRNATransfectionActinsCollagen Type IOncogene Protein v-aktPhosphatidylinositol 3-Kinasesrac1 GTP-Binding ProteinRAC1 protein, humanrhoA GTP-Binding Proteinrho GTP-Binding ProteinsRNATransforming Growth Factor beta

Identifiers

PMID19726546
PMCPMC2781339
OpenAlexW2166678824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.